Ballentine Partners, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,146,231
+8.5%
11,253
+7.5%
0.03%
+12.5%
Q2 2023$1,056,528
+42.4%
10,470
+29.8%
0.02%
+26.3%
Q1 2023$742,164
+3.5%
8,067
+2.0%
0.02%
-9.5%
Q4 2022$717,323
-2.5%
7,907
-18.4%
0.02%
-16.0%
Q3 2022$736,000
-9.8%
9,692
+0.4%
0.02%
-13.8%
Q2 2022$816,000
-24.4%
9,654
-21.5%
0.03%
-14.7%
Q1 2022$1,080,000
+42.9%
12,305
+42.4%
0.03%
+47.8%
Q4 2021$756,000
+7.2%
8,644
+0.2%
0.02%
-4.2%
Q3 2021$705,000
-4.7%
8,624
+6.4%
0.02%
-7.7%
Q2 2021$740,000
+6.8%
8,106
-0.1%
0.03%0.0%
Q1 2021$693,000
-14.8%
8,116
-5.7%
0.03%
-18.8%
Q4 2020$813,000
+11.1%
8,606
+2.3%
0.03%0.0%
Q3 2020$732,000
+4.6%
8,412
+4.8%
0.03%
-3.0%
Q2 2020$700,000
+2.2%
8,024
-3.5%
0.03%
-17.5%
Q1 2020$685,000
-18.2%
8,317
-5.9%
0.04%
+5.3%
Q4 2019$837,000
+14.7%
8,838
+5.3%
0.04%
+11.8%
Q3 2019$730,000
-4.1%
8,391
+0.8%
0.03%
-8.1%
Q2 2019$761,000
-0.8%
8,328
+4.5%
0.04%
-7.5%
Q1 2019$767,000
+17.1%
7,969
+4.5%
0.04%
+5.3%
Q4 2018$655,000
+9.5%
7,629
+9.8%
0.04%
+22.6%
Q3 2018$598,000
+15.9%
6,948
+1.7%
0.03%
+6.9%
Q2 2018$516,000
-6.5%
6,829
+0.1%
0.03%
-6.5%
Q1 2018$552,000
-1.6%
6,821
+2.2%
0.03%0.0%
Q4 2017$561,000
+0.7%
6,674
+2.9%
0.03%0.0%
Q3 2017$557,000
-1.1%
6,485
-3.6%
0.03%
-24.4%
Q2 2017$563,000
+52.2%
6,728
+35.3%
0.04%
+57.7%
Q1 2017$370,000
-8.2%
4,972
-10.1%
0.03%
-16.1%
Q4 2016$403,000
+2.8%
5,533
+11.5%
0.03%
-3.1%
Q3 2016$392,000
-6.0%
4,963
-1.8%
0.03%
-8.6%
Q2 2016$417,000
+28.7%
5,056
+12.9%
0.04%
+20.7%
Q1 2016$324,000
-18.6%
4,479
-2.9%
0.03%
-25.6%
Q4 2015$398,000
-0.5%
4,615
+6.1%
0.04%
-7.1%
Q3 2015$400,000
+4.7%
4,349
+12.1%
0.04%
+13.5%
Q2 2015$382,000
-0.3%
3,8790.0%0.04%
-2.6%
Q1 2015$383,000
-72.2%
3,879
-73.9%
0.04%
-76.1%
Q4 2014$1,376,000
+277.0%
14,859
+283.1%
0.16%
+269.8%
Q3 2014$365,000
+4.0%
3,8790.0%0.04%
+2.4%
Q2 2014$351,000
+6.7%
3,8790.0%0.04%
+7.7%
Q1 2014$329,000
+12.3%
3,879
+6.3%
0.04%
+18.2%
Q4 2013$293,000
+4.6%
3,6500.0%0.03%
-2.9%
Q3 2013$280,000
+8.5%
3,6500.0%0.03%
-2.9%
Q2 2013$258,0003,6500.04%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders